Sun Pharma Qualifies in Top 5% of Pharmaceutical Companies in S&P Global Sustainability Yearbook 2025

Sun Pharmaceutical Industries Ltd has been included in the S&P Global Sustainability Yearbook 2025, qualifying in the Top 5% of pharmaceutical companies assessed by S&P globally. This recognition attests to Sun Pharma’s commitment to incorporate Environmental, Social, and Governance (ESG) principles through focused initiatives across its businesses. The report highlights Sun Pharma’s focus on sustainability, its priorities, its goals and achievements, and its commitment to reducing environmental impacts and combating climate change. The company has achieved a 24.69% reduction in its absolute Scope 1 and Scope 2 carbon emissions till date, compared to the baseline year of 2020, and aims to achieve a 35% reduction by 2030. Sun Pharma is also dedicated to respecting human rights and promoting inclusion amongst its workforce.